Answers are grounded in this paper and cite their sources.
Cold tumors often resist immunotherapy because local therapeutic injury is poorly coupled to inflammatory cell death and antigen-presenting cell activation. Here, we develop a redox-adaptive N-oxide zwitterionic nanogel, PODMMA, that directs pyropheophorbide a (Ppa)-mediated photodynamic injury to mitochondria and converts local phototherapy into gasdermin-mediated immune ignition. Mechanistic analyses suggest that PODMMA facilitates mitochondrial enrichment of Ppa through endoplasmic reticulum-associated trafficking and glutathione-responsive charge conversion. Upon irradiation, PODMMA-Ppa triggers mitochondrial depolarization, caspase-1/gasdermin D activation, membrane rupture, and release of lactate dehydrogenase, adenosine triphosphate, and interleukin 1β. These photopyroptotic signals activate dendritic cells, enhance inflammatory remodeling, recruit T cells, and suppress tumor growth, with favorable biosafety. This study establishes organelle-programmed photopyroptosis as a biomaterials-enabled strategy for transforming photodynamic therapy from local cytotoxicity into antitumor immune activation.
No takes yet. Share an insight, caveat, or question.
Diao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: